DEMONSTRATION OF NEUROPEPTIDE-Y AND ITS PRECURSOR IN PLASMA AND FOLLICULAR-FLUID

被引:11
作者
JORGENSEN, JC
OHARE, MMT
ANDERSEN, CY
机构
[1] UNIV COPENHAGEN,RIGSHOSP,DEPT OBSTET & GYNECOL,DK-2100 COPENHAGEN,DENMARK
[2] UNIV COPENHAGEN,RIGSHOSP,REPROD BIOL LAB 2,DK-2100 COPENHAGEN,DENMARK
关键词
D O I
10.1210/endo-127-4-1682
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present investigation provides three lines of evidence for the presence of a pro-form of neuropeptide Y (NPY) in plasma and follicular fluid. First, by the demonstration of NPY-immunoreactive material of a size corresponding to the estimated mol wt of pro-NPY. Second, an antiserum specific for the C-terminal tyrosine amide of NPY and peptide YY does not react with this material. Third, it was possible to convert the pro-NPY extracted from plasma and follicular fluid using the protease, Endoproteinase-Lys C, to a NPY-immunoreactive form eluting slightly before NPY on a G-50 column. The size of the digested product was consistent with a cleavage of pro-NPY resulting in an immunoreactive species, NPY-Gly-Lys. Pro- NPY was also found in tissue culture media from the human neuroendocrine cell line SH-SY5Y. As in the case of plasma and follicular fluid, another NPY immunoreactive species eluted from a G-50 gel filtration column slightly before synthetic human NPY. Analysis of this material with an antibody directed against the tyrosine amide of NPY in combination with isoelectric focusing revealed that this peak consisted of at least two immunoreactive forms of NPY. In conclusion, at least three different forms of NPY immunoreactivity are likely to be present in plasma, follicular fluid, and cell tissue culture media: Pro- NPY, a degradation form of pro-NPY, or a biosynthetic intermediate and NPY. © 1990 by The Endocrine Society.
引用
收藏
页码:1682 / 1688
页数:7
相关论文
共 33 条
[21]  
OHARE MMT, 1989, CANCER RES, V49, P7015
[22]  
OHARE MMT, 1989, CANCER RES, V49, P7010
[23]  
PAPKA RE, 1985, CELL TISSUE RES, V242, P475
[24]  
PERNOW J, 1986, CLIN PHYSIOL, V6, P561
[25]   VASOCONSTRICTOR EFFECTS INVIVO AND PLASMA DISAPPEARANCE RATE OF NEUROPEPTIDE-Y IN MAN [J].
PERNOW, J ;
LUNDBERG, JM ;
KAIJSER, L .
LIFE SCIENCES, 1987, 40 (01) :47-54
[26]   RELEASE AND VASOCONSTRICTOR EFFECTS OF NEUROPEPTIDE-Y IN RELATION TO NON-ADRENERGIC SYMPATHETIC CONTROL OF RENAL BLOOD-FLOW IN THE PIG [J].
PERNOW, J ;
LUNDBERG, JM .
ACTA PHYSIOLOGICA SCANDINAVICA, 1989, 136 (04) :507-517
[27]   MECHANISMS UNDERLYING PREJUNCTIONAL AND POSTJUNCTIONAL EFFECTS OF NEUROPEPTIDE-Y IN SYMPATHETIC VASCULAR CONTROL [J].
PERNOW, J ;
SARIA, A ;
LUNDBERG, JM .
ACTA PHYSIOLOGICA SCANDINAVICA, 1986, 126 (02) :239-249
[28]   NEUROPEPTIDE-Y AS AN AUTONOMIC NEUROTRANSMITTER [J].
POTTER, EK .
PHARMACOLOGY & THERAPEUTICS, 1988, 37 (02) :251-273
[29]  
SCHWARTZ TW, 1989, MOL BIOL ISLETS LANG, P153
[30]  
SHEIKH SP, 1989, J BIOL CHEM, V264, P6648